Kolexia
Dulac Yves
Pédiatrie
Hôpital Paule de Viguier
Toulouse, France
367 Activités
941 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cardiopathies congénitales Cardiopathies Syndrome de Marfan Communications interventriculaires Entorses et foulures Communications interauriculaires Bloc atrioventriculaire Anévrysme Anévrysme de l'aorte

Industries

Servier
7 collaboration(s)
Dernière en 2021
Abbvie
1 collaboration(s)
Dernière en 2020
Actelion
1 collaboration(s)
Dernière en 2020
AstraZeneca
1 collaboration(s)
Dernière en 2022

Dernières activités

Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial.
European heart journal   02 mars 2024
Usefulness of perioperative transoesophageal echocardiography during paediatric cardiac surgery.
Archives of cardiovascular diseases   17 janvier 2024
Advancing paediatric cardiac imaging: a comprehensive analysis of the feasibility and accuracy of a novel 3D paediatric transoesophageal probe.
Frontiers in cardiovascular medicine   05 décembre 2023
SOPHRO CARE: Impact of Sophrology on Exercise Capacity of Adolescents and Young Adults With Congenital Heart Disease : Multicenter Randomized Controlled Trial
Essai Clinique (CHU Montpellier)   02 octobre 2023
Assessment of tricuspid annulus geometry in children with CHD using 3D echocardiography
FCPC 2023   01 septembre 2023
Safety and efficiency of the new 3D transoesophageal pediatric probe in paediatric cardiology
FCPC 2023   01 septembre 2023
Dysplasie broncho-pulmonaire
HAS Publications   10 août 2023
Primary Non-Aortic Lesions Are Not Rare in Marfan Syndrome and Are Associated with Aortic Dissection Independently of Age.
Journal of clinical medicine   17 avril 2023
M3C Academy Aorte ascendante Aortopathies héréditaires Yves Dulac
Youtube @ M3C-Carpedem   01 mars 2023
QUALIREHAB: Impact of Cardiovascular Rehabilitation on the Quality of Life of Adolescents and Young Adults With Congenital Heart Disease: A Randomized Controlled Multicentre Trial
Essai Clinique (CHU Montpellier)   30 janvier 2023